SELE20

Welcome to the Brand page for “SELE20”, which is offered here for Therapeutic pharmaceutical for the treatment of complement related diseases and pathologies;sele twenty;.

Its status is currently believed to be active. Its class is unavailable. “SELE20” is believed to be currently owned by “NovelMed Therapeutics”.


Owner:
NOVELMED THERAPEUTICS
Owner Details
Description:
Therapeutic pharmaceutical for the treatment of complement related diseases and pathologies;SELE TWENTY;
Categories: THERAPEUTIC PHARMACEUTICAL TREATMENT